What Happened?
San Diego, CA-based NexMed appointed Mark Wilson as vice president of Technology Development.
About the Company
NexMed, Inc. (NASDAQ: NEXM), due to its recent acquisition of Bio-Quant, Inc., a revenue-generating specialty contract research organization performing in vitro and in vivo pharmacology services, is now the largest specialty CRO based in San Diego, CA.
About the Person
Mark Wilson was previously the entrepreneur-in-residence at CONNECT in San Diego. Prior to that, he served for five years as vice president of Business Development at Halozyme Therapeutics.
Info Source
News
Short Profile